Piffaretti Gabriele, Bacuzzi Alessandro, Gattuso Andrea, Mozzetta Gaddiel, Cervarolo Maria Cristina, Dorigo Walter, Castelli Patrizio, Tozzi Matteo
Vascular Surgery-Department of Medicine and Surgery, Circolo University Teaching Hospital, University of Insubria School of Medicine, Via Guicciardini 9, 21100, Varese, Italy.
Anesthesia and Palliative Care, Circolo University Teaching Hospital, University of Insubria School of Medicine, Varese, Italy.
World J Surg. 2019 Jan;43(1):273-281. doi: 10.1007/s00268-018-4768-6.
Surgical decision making remains difficult in several patients with aneurysmal disease of the descending thoracic (DT) or thoracoabdominal (TA) aorta. Despite previous studies that have investigated aneurysms treated non-operatively using a prospective growth analysis, completeness and accuracy of follow-up were inconsistent. We aim to describe the survival and freedom from adverse aortic events in patients with DT and TA who did not undergo operative repair.
This is a single-center retrospective analysis of all patients with either a descending degenerative atherosclerotic or dissection-related DT or TA aortic lesion who were treated non-operatively from April 2002 to December 2016. We studied patients who did not undergo operative repair of descending degenerative atherosclerotic or dissection-related DT or TA aortic lesion. Primary end points were overall survival and freedom from aortic-related mortality (ARM).
Of the 315 patients diagnosed with DT or TA disease, 56 (18%) did not undergo surgical repair. Mean aneurysm diameter was 65 mm ± 15 (range 50-120; IQR 5.4-7.15). Extent of the aortic aneurysms was DT in 36 (11%) patients and TA in 20 (6%). Median duration of follow-up was 12 months (range 1-108; IQR 3-36). Over the course of the study, 41 (73%) patients died for an overall survival rate of 53% ± 7 at 1 year (95% CI 40-65) and 23% ± 7 at 3 year (95% CI 17-42.5). Aortic-related mortality was 27% (n = 15), significantly higher in patients with aneurysms ≥ 60 mm [n = 13, (39%) vs. n = 2, (9%); P = 0.025; OR = 5.04]. Overall, estimated freedom from ARM was 81% ± 5.5 at 1 year (95% CI 68-89) and 66.5% ± 9 at 3 year (95% CI 48-81). Only TA extent was independently associated with freedom from ARM during the follow-up (P = 0.005; HR: 5.74; 95% CI 1.711-19.729).
Thoracoabdominal extent of the aneurysmal aortic disease is the most important predictor of ARM in unrepaired DT or TA aortic diseases. Mortality from aortic-related events was significantly more premature than mortality from non-aortic-related mortality.
对于一些患有降主动脉(DT)或胸腹主动脉(TA)动脉瘤疾病的患者,手术决策仍然困难。尽管先前的研究通过前瞻性生长分析对非手术治疗的动脉瘤进行了调查,但随访的完整性和准确性并不一致。我们旨在描述未接受手术修复的DT和TA患者的生存率及无主动脉不良事件的情况。
这是一项单中心回顾性分析,研究对象为2002年4月至2016年12月期间接受非手术治疗的所有患有降主动脉退行性动脉粥样硬化或与夹层相关的DT或TA主动脉病变的患者。我们研究了未接受降主动脉退行性动脉粥样硬化或与夹层相关的DT或TA主动脉病变手术修复的患者。主要终点是总生存率和无主动脉相关死亡率(ARM)。
在315例被诊断为DT或TA疾病的患者中,56例(18%)未接受手术修复。动脉瘤平均直径为65 mm±15(范围50 - 120;四分位间距5.4 - 7.15)。36例(11%)患者的主动脉瘤范围为DT,20例(6%)为TA。中位随访时间为12个月(范围1 - 108;四分位间距3 - 36)。在研究过程中,41例(73%)患者死亡,1年时总生存率为53%±7(95%置信区间40 - 65),3年时为23%±7(95%置信区间17 - 42.5)。主动脉相关死亡率为27%(n = 15),动脉瘤≥60 mm的患者中该死亡率显著更高[n = 13,(39%)对n = 2,(9%);P = 0.025;比值比=5.04]。总体而言,1年时估计无ARM的比例为81%±5.5(95%置信区间68 - 89),3年时为66.5%±9(95%置信区间48 - 81)。在随访期间,只有TA范围与无ARM独立相关(P = 0.005;风险比:5.74;95%置信区间1.711 - 19.729)。
在未修复的DT或TA主动脉疾病中,胸腹主动脉瘤疾病的范围是ARM的最重要预测因素。主动脉相关事件导致的死亡率比非主动脉相关死亡率显著更早。